Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIA in Hip Arthroplasty Fast Track Program
NCT03513276Phase 4Completed
- Sponsor
- Hospital Universitari MútuaTerrassa
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in hip osteoarthritis, sponsored by Hospital Universitari MútuaTerrassa. Started Feb 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT03513276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03513276.